Physician profile
Gerald B Sullivan
NPI 1154396927
$2,381.54
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,555 · 2020: $593 · 2021: $151 · 2022: $27.45 · 2023: $55.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $669.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $324.92 | 2019-2020 | |
| Pfizer INC. | $278.81 | 2019-2020 | |
| Novo Nordisk INC | $169.14 | 2019-2020 | |
| Astellas Pharma US INC | $142.06 | 2019-2020 | |
| Glaxosmithkline, LLC. | $133.59 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.06 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $96.17 | 2019-2020 | |
| Abbvie INC. | $84.91 | 2021-2023 | Ubrelvy |
| Merck Sharp & Dohme LLC | $76.24 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $54.91 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.54 | 2019-2020 | |
| Sanofi Pasteur INC. | $36.67 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $30.37 | 2019-2020 | |
| Eisai INC. | $27.27 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $23.49 | 2023 | Repatha |
| Allergan, INC. | $18.60 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.84 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.83 | 2019 | |
| Genentech USA, INC. | $13.33 | 2020 | |
| Biodelivery Sciences International, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.